FAS and B-cell chronic lymphocytic leukemia: However, another study showed that CCDC50 maintains long-term activation of NF-κB signaling in Fas-stimulated thymocytes [22], and CCDC50 is required for tumor survival and activates NF-κB signaling in CLL and MCL [13].